Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2003
03/13/2003WO2003021228A2 Heteroaryl substituted benzothiazole dioxetanes
03/13/2003WO2003021227A2 Methods and compositions useful for diagnosis, staging, and treatment of cancers and tumors
03/13/2003WO2003021226A2 Peptide biomarker and method of identification
03/13/2003WO2003021225A2 Method for classification of anti-psychotic drugs
03/13/2003WO2003021224A2 Methods for identifying heterozygous carriers of autosomal recessive diseases
03/13/2003WO2003021223A2 Methods for qualitative and quantitative analysis of cells and related optical bio-disc systems
03/13/2003WO2003021221A2 Method for discovering new infectious particles
03/13/2003WO2003021220A2 Assays for inositol phosphates
03/13/2003WO2003021010A2 Methods for the specific detection of redox-active tags and the use thereof for capillary gel electrophoresis and dna sequencing
03/13/2003WO2003020986A1 Method of isolating cells and uses thereof
03/13/2003WO2003020985A1 Detection of genetic sequences using a bipartite probe
03/13/2003WO2003020984A2 Terminal-phosphate-labeled nucleotides and methods of use
03/13/2003WO2003020983A1 Allele specific pcr for genotyping
03/13/2003WO2003020982A1 A method to determine the risk for side effects of an ssri treatment in a person
03/13/2003WO2003020981A1 Nucleic acid archiving
03/13/2003WO2003020980A2 Single nucleotide polymorphisms diagnostic for schizophrenia
03/13/2003WO2003020979A1 Methods for preparing nucleic acid samples
03/13/2003WO2003020978A1 Method for manufacturing hydrogel biochip by using star-like polyethylene glycol derivative having epoxy group
03/13/2003WO2003020977A2 Nucleotide repeats assay
03/13/2003WO2003020976A2 Oligonucleotides for use in detection of human papillomavirus e7 mrna
03/13/2003WO2003020975A2 OLIGONUCLEOTIDES FOR USE IN DETECTION OF HUMAN PAPILLOMAVIRUS L1 mRNA
03/13/2003WO2003020974A2 Methods for detecting dna originating from different individuals in one sample
03/13/2003WO2003020973A2 Polymorphic sex testing method
03/13/2003WO2003020972A1 Molecular identification of staphylococcus-type bacteria
03/13/2003WO2003020971A2 Novel method of detecting a mutation in read phase in a coding sequence and the apparatus used to carry out same
03/13/2003WO2003020970A2 New hepatitis c virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
03/13/2003WO2003020969A2 Method for marking l-nucleic acids
03/13/2003WO2003020968A2 Method for analyzing nucleic acid sequences and gene expression
03/13/2003WO2003020967A1 A method for the determination of multiple analytes
03/13/2003WO2003020966A2 Surface for the immobilisation of nucleic acids
03/13/2003WO2003020965A2 Use of snps of mch-r for identifying genetic disorders in maintaining the normal body weight
03/13/2003WO2003020964A1 Means and methods for determining the presence of active herpes virus
03/13/2003WO2003020963A2 Proteins in type 2 diabetes
03/13/2003WO2003020962A2 Method of identifying glycosyl transferase binding compounds
03/13/2003WO2003020961A1 Method of determining thiopurine methyltransferase (tpmt) activity in erythrocytes
03/13/2003WO2003020960A1 Method of determining target protein of drug
03/13/2003WO2003020959A1 Products containing quantum of bioparticles and method for production thereof
03/13/2003WO2003020954A2 205p1b5 in treatment and detection of cancer
03/13/2003WO2003020953A2 Compositions and methods relating to colon specific genes and proteins
03/13/2003WO2003020952A2 Affinity-shifted probes for quantifying analyte polynucleotides
03/13/2003WO2003020950A2 Methods and compositions for bi-directional polymorphism detection
03/13/2003WO2003020949A2 Targeted nucleic acid constructs and uses related thereto
03/13/2003WO2003020947A2 Mid 9002, a human sulfatase family member and uses therefor
03/13/2003WO2003020934A1 Compositions and methods relating to colon specific genes and proteins
03/13/2003WO2003020933A1 Novel serine protease inhibitory protein mt0039
03/13/2003WO2003020931A2 Sirna knockout assay method and constructs
03/13/2003WO2003020930A1 IDENTIFICATION AND USE OF MAMMALIAN p21 INHIBITORS
03/13/2003WO2003020928A2 Identification of eukaryotic internal ribosome entry site (ires) elements
03/13/2003WO2003020927A2 Creation of artificial internal ribosome entry site (ires) elements
03/13/2003WO2003020922A2 Enzymes involved in cell wall biosynthesis in filamentous fungi
03/13/2003WO2003020918A1 Mediucm for detecting vana and vanb vancomycin-resistant enterococci and method of using the same
03/13/2003WO2003020912A2 Novel clark protein and nucleic acid molecules and uses therefor
03/13/2003WO2003020911A2 Human schizophrenia gene
03/13/2003WO2003020909A2 Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders
03/13/2003WO2003020907A2 Histamine receptor h4 polynucleotides
03/13/2003WO2003020905A2 Nucleic acid compositions conferring disease resistance
03/13/2003WO2003020902A2 Methods for blocking nonspecific hybridizations of nucleic acid sequences
03/13/2003WO2003020901A2 Compositions and methods relating to prostate specific genes and proteins
03/13/2003WO2003020900A2 Compositions and methods relating to breast specific genes and proteins
03/13/2003WO2003020899A2 Compositions and methods relating to lung specific genes and proteins
03/13/2003WO2003020898A2 Arrays comprising pre-labeled biological molecules and methods for making and using these arrays
03/13/2003WO2003020896A2 Production of cultured human mast cells and basophils for high throughput small molecule drug discovery
03/13/2003WO2003020895A2 Method of determining the nucleotide sequence of oligonucleotides and dna molecules
03/13/2003WO2003020892A2 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY
03/13/2003WO2003020891A2 Single nucleotide amplification and detection by polymerase
03/13/2003WO2003020890A2 Genes encoding baeyer-villiger monooxygenases
03/13/2003WO2003020889A2 Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
03/13/2003WO2003020887A2 Gene identification
03/13/2003WO2003020882A2 Inhibition of viral replication by targeting rna-dna complexes
03/13/2003WO2003020878A2 Amplification and detection reagents for hiv-1
03/13/2003WO2003020877A2 Staining and sorting genomes and chromosomes using sequence-specific polyamides
03/13/2003WO2003020875A2 Staphylococci surface-exposed immunogenic polypeptides
03/13/2003WO2003020873A2 Reproduction of ribonucleic acids
03/13/2003WO2003020766A1 Late gestation lung genes, fragments and uses thereof
03/13/2003WO2003020761A1 Modified human growth hormone
03/13/2003WO2003020757A2 Novel genetic products obtained from ashbya gossypii, which are associated with transcription mechanisms, rna processing and/or translation
03/13/2003WO2003020751A2 Homing peptides
03/13/2003WO2003020742A1 Assay for detection of human parvovirus b19 nucleic acid
03/13/2003WO2003020740A1 Array using microspheres
03/13/2003WO2003020739A2 Novel lna compositions and uses thereof
03/13/2003WO2003020734A2 Labeled nucleoside polyphosphates
03/13/2003WO2003020702A2 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
03/13/2003WO2003020287A2 Methods for the treatment of chronic pain anc compositions therefor
03/13/2003WO2003020220A2 Mitochondrial biology expression arrays
03/13/2003WO2003020120A2 Diagnosis and treatment of vascular disease
03/13/2003WO2003020118A2 Diagnosis and treatment of vascular disease
03/13/2003WO2003020013A1 Plant-derived resistance gene
03/13/2003WO2003000856A3 In vitro protein interaction detection systems
03/13/2003WO2003000839A3 Clinical assay for nucleic acids amplified in solid matrices to produce colonies of the progeny of individual target molecules
03/13/2003WO2003000418A3 Microfluidic system including a virtual wall fluid interface port for interfacing fluids with the microfluidic system
03/13/2003WO2002103013A3 Partially double-stranded nucleic acids, methods of making, and use thereof
03/13/2003WO2002099038A3 Adsls as modifiers of the p53 pathway and methods of use
03/13/2003WO2002097413A3 Electrochemical dna-sensor, method for producing and operating a dna-sensor of this type
03/13/2003WO2002095055A8 Compositions and methods for use in isolation of nucleic acid molecules
03/13/2003WO2002090930A3 Stabilizing peroxides with stannous halides
03/13/2003WO2002086095A3 Transcription factor network discovery methods
03/13/2003WO2002082051A3 An integrated high throughput system for the analysis of biomolecules
03/13/2003WO2002077217A3 Human dual specificity protein phosphatase 7-like protein
03/13/2003WO2002074979A3 Expression profiles and methods of use
03/13/2003WO2002071928A3 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
1 ... 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 2171 ... 3003